Dr Christophe Bureau
Toulouse, Hôpital Rangueil, 31000, France
NCT Number: NCT01080144
All patients eligible for TIPS (Transjugular intrahepatic portosystemic shunt) procedure will be considered for inclusion. After written inform consent, psychometric tests in order to calculate the psychometric hepatic encephalopathy (PHES) score, the gold standard for the diagnosis of minimal encephalopathy and critical flicker frequency (CFF) will be performed before the TIPS procedure. After TIPS, patients will be followed during one year and the psychometric test and CFF will be performed every 3 months.
30 patients will be included.
The main endpoint is the success rate of CFF. The secondary end points are
* Correlation between CFF and PHES score * Performance of CFF and PHES score to predict the occurrence of overt encephalopathy after TIPS procedure * A sample collection during TIPS procedure is also performed for validation of biomarkers
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toulouse, Hôpital Rangueil, 31000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After TIPS, patients will be followed during one year and the psychometric test and Critical flicker frequency procedure will be performed every 3 months
Time frame: before TIPS and every 3 months till one year
number of patients in whom ten measurement will be available / 30 patients
Time frame: every 3 months till one year after TIPS procedure
University Hospital, Toulouse
Other
A Pilot Study Aiming to Assess the Feasibility of Critical Flicker Frequency for the Diagnosis of Minimal Encephalopathy in Patients With Cirrhosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01842581
Brain Diseases, Brain Diseases, Metabolic
Phoenix, Arizona, United States
View Trial DetailsNCT02650245
Brain Diseases, Central Nervous System Diseases
Bethlehem, Pennsylvania, United States
View Trial DetailsNCT00764049
Acute on Chronic Hepatic Failure, Acute-On-Chronic Liver Failure
Clichy, France
View Trial DetailsNCT01231828
Brain Diseases, Central Nervous System Diseases
Caen, France
View Trial Details